Riyadh, Saudi Arabia

Abdullah Mussad Alenizi

This inventor holds 1 USPTO granted patent. Top assignee: King Saud University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdullah Mussad Alenizi. Retrieved from https://idiyas.com/inventor/abdullah-mussad-alenizi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abdullah Mussad Alenizi: Inventor of Gum Olibanum Nanofibers

Introduction

Abdullah Mussad Alenizi is an inventor associated with King Saud University in Riyadh, Saudi Arabia. His work includes a patent on gum olibanum nanofibers for drug release and wound healing applications.

Latest Patents

Alenizi is credited with 1 patent: “Gum olibanum nanofibers for drug release and wound healing applications.” The invention describes methods for producing gum olibanum nanofibers by mixing gum olibanum with acetic acid, adding water, stirring in polyvinyl alcohol, and electrospinning the mixture. It also describes making composite nanofibers by combining the fibers with a nanoparticle solution and electrospinning them again. These materials are proposed for controlled drug release and wound healing applications.

Career Highlights

Alenizi is associated with King Saud University, a research institution in Riyadh. His patent focuses on nanofiber fabrication and potential biomedical uses.

Collaborations

The listed coworkers associated with this work are Afrah Fahad Alkhuriji and Manal Ahmed Awad.

Conclusion

Abdullah Mussad Alenizi’s patented work explores gum olibanum nanofibers as materials for controlled drug delivery and wound healing.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…